Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01252797 · ClinicalTrials.gov registry record · Phase 1
Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002)
A Phase 1 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01252797 is a Phase 1 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants.
The verdict
NCT01252797, a Phase 1 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will investigate the safety, tolerability, and effectiveness of changing the order of receiving radiation therapy for treating brain cancer. The investigators hope that changing the sequence of radiation therapy will lower the risk of cancer spreading throughout your spinal fluid, which covers your brain and spinal cord.
Interventions
- RADIATION Stereotactic Radiosurgery (15 Gy)
- RADIATION Stereotactic Radiosurgery (12 Gy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-10 |
| Est. Completion | 2018-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01252797
The ClinicalTrials.gov registry entry for NCT01252797 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stereotactic Radiosurgery (15 Gy) is the first listed.
NCT01252797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01252797 about?
NCT01252797 is a clinical study titled "Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002)". This study will investigate the safety, tolerability, and effectiveness of changing the order of receiving radiation therapy for treating brain cancer. The investigators hope that changing the sequence of radiation therapy will lower the risk of cancer spreading throughout your spinal fluid, which c...
What is the current status of trial NCT01252797?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2010-10. Estimated completion is 2018-04.
What interventions are being tested in trial NCT01252797?
The interventions under investigation include: Stereotactic Radiosurgery (15 Gy) (RADIATION), Stereotactic Radiosurgery (12 Gy) (RADIATION).
Who is sponsoring clinical trial NCT01252797?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.